Delivery Order SPE2DB20D7059-SPE2DB23FQFK7
Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $58,000 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. The order is to provide 456,156 units of ketorolac 30 mg/ml vials for use by the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from July 21 through July 24, 2023. The delivery order was issued under an existing Amerisourcebergen...
- The Defense Logistics Agency awarded a $307 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable vials. As the prime contractor, Amerisourcebergen will supply 15 mg/ml vials of ketorolac, an injectable nonsteroidal anti-inflammatory drug, for use by the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from August 25 to August 28, 2023. No subcontractors or set aside...
- The Defense Logistics Agency Troop Support Medical awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 30 mg/mL vials of ketorolac from its Conshohocken, Pennsylvania facility by September 22, 2023 to support DLA medical programs. No subcontractors or set aside designations were identified. Ketorolac is a nonsteroidal anti-inflammatory drug used for short-term management of moderate to...
- The Defense Logistics Agency awarded a $1,273 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injections. Under this order, Amerisourcebergen will provide 4561598148 units of ketorolac 30 mg/ml vials to be delivered from its facility in Conshohocken, Pennsylvania. The order was awarded on July 25, 2023 and concludes on July 26, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's...
- The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. The firm fixed price order is for the delivery of ketorolac 30 mg/ml vials to a facility in Conshohocken, Pennsylvania between September 14-15, 2023. Amerisourcebergen will provide the injectable pain medication to support Department of Defense requirements under the agency's Prime Vendor Program indefinite-delivery/indefinite-quantity contract. No subcontractors...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $485 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4561739631 units of ketorolac 30 mg/ml vials from its Conshohocken, Pennsylvania facility for use by the Department of Defense. The single-day order was placed under an existing Amerisourcebergen contract vehicle and is intended to support DLA's medical product procurement programs. No...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $724 to Amerisourcebergen Drug Corporation for ketorolac injectable solution. As the prime contractor, Amerisourcebergen will supply 4561653311 units of ketorolac 30 mg/ml vials from its facility in Conshohocken, Pennsylvania, with performance required between July 31 and August 1, 2023. The order was placed under an existing DLA contract vehicle to support the agency's medical supply needs. No...
- The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. Under this firm fixed price contract, Amerisourcebergen will provide 456,195 vials of 30 mg/ml ketorolac to support Defense Logistics Agency pharmaceutical requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 28, 2023. No subcontractors or set aside designations were identified. This order is consistent with...
- The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. Under this firm fixed price contract, Amerisourcebergen will provide 4562152905 ketorolac 30 mg/ml vials to support Defense Logistics Agency requirements from its facility in Conshohocken, Pennsylvania. The contract runs from September 11-12, 2023 to deliver the requested pharmaceutical products. No subcontractors or set aside designations were specified. This...
- The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. This firm fixed price order is being fulfilled under the Prime Vendor Pharmaceutical program and calls for the delivery of ketorolac 30 mg/ml vials to a Defense Logistics Agency location in Conshohocken, Pennsylvania. The order period of performance is from August 25, 2023 through August 28, 2023. No subcontractors or set aside designations were identified. The...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB23FQFK7Delivery Order
The Defense Logistics Agency awarded a $2,907 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. The order is for 4561602694 units of ketorolac 30 mg/ml vials to be delivered by July 27, 2023 from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug used for short-term management of moderately severe acute pain. This delivery order was issued under the DLA's Pharmaceutical Prime Vendor contract, a multiple award indefinite delivery/indefinite quantity vehicle used to fulfill pharmaceutical requirements for the Military Health System and other DOD customers. No subcontractors or set aside designations were identified.
Generated 12/24/23, 2:35 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/26/23 |